sprite-preloader
Anzeige
Mehr »
Samstag, 15.12.2018 Börsentäglich über 12.000 News von 601 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von BioPharma-Reporter

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrOrchard to build $80m gene therapy manufacturing facility
DoStable 2019 predicted for pharma despite political and regulatory risk, finds credit agency
DoHired and retired: Year's end edition
MiCambrex continues build-out at former PharmaCore site with $1m investment
MiChinese firm plans 'first-in-class' biologics after $325m manufacturing investment
MiInsulin biosimilars? US FDA readies market for entry
DiBiotage acquires Phynexus in $21.5m deal
DiLonza and GE look to China with development of biologics facility
MoOxford BioMedica to capture 25-30% of lentiviral vector market by 2026, predicts CTO
07.12.WuXi Biologics: Ireland's largest single-use facility underway
07.12.UK-funded study to investigate patients' experience of cell and gene therapies
06.12.Tech focus: Making waves with acoustic separation in cell processing
05.12.Leukemia licensing deal could potentially cost Janssen more than $1.8bn
05.12.Catalent expands biologics facility, to create 36 new jobs
05.12.Leukemia licensing deal may cost Janssen more than $1.3bn
05.12.Start-up develops cell replacement therapy to 'make hair loss history'
04.12.Samsung BioLogics CEO responds to regulator's accountancy claims
04.12.AbbVie secures another Humira patent deal
30.11.Five big pharma deals in Humira market could save UK £300m
30.11.Bayer to shed €600m factor VIII facility and 12,000 staff
30.11.Celltrion and Teva announce first Rituxan biosimilar approval in US
29.11.WuXi Biologics wins ABL Bio contract for bispecific antibodies
28.11.Giving patients a choice: Genentech RA auto-injector product approved in US
28.11.Pall, Cobra and CGTC collaborate on continuous method for gene therapies
27.11.UK vows to speed up drug review in return for 2% sales cap